Johnson & Johnson (FRA:JNJ)

Market Cap	460.84B +35.9%
Revenue (ttm)	80.06B +6.0%
Net Income	22.78B +90.6%
EPS	9.38 +90.5%
Shares Out	n/a
PE Ratio	20.23
Forward PE	19.50
Dividend	4.57 (2.40%)
Ex-Dividend Date	Nov 25, 2025

Volume	565
Average Volume	526
Open	190.02
Previous Close	190.42
Day's Range	189.00 - 191.26
52-Week Range	129.00 - 192.02
Beta	n/a
RSI	68.34
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2025, Johnson & Johnson's revenue was $94.19 billion, an increase of 6.05% compared to the previous year's $88.82 billion. Earnings were $26.80 billion, an increase of 90.56%.

Financial numbers in USD